The Challenge of Liver Toxicity
in Drug Development.
Testing Limitations (ALT / AST)
Traditional indicators lack specificity and are released by non-hepatic tissues, leading to false safety flags that incorrectly kill viable drug candidates.
PCR's Fatal Flaw: isomiRs
PCR cannot distinguish miRNA variants (isomiRs): degradation products that create false negatives. This renders PCR unreliable for clinical miRNA diagnostics.
Lost opportunities from false positive signals and late-stage failures due to hepatotoxicity
DILI is the leading cause of acute liver failure worldwide
LiverAce™ Singleplex Kit
Accurate PCR-free miRNA-122 detection
miRNA-122 is well established as an early biomarker for drug-induced liver toxicity from liver organoids, across small and large animal species and in humans. miRNA-122 rises much earlier and is more liver specific than traditional enzymes, such as AST/ALT, providing the high specificity required to eliminate false toxicity flags. By overcoming the miRNA degradation to isomers challenge that plagues the use of PCR for miRNAs, LiverAce™ Singleplex delivers the “Fail-Fast” precision required for confident drug development.
For Research Use Only
Not for use in diagnostic procedures
Complete drug development process
One assay for the complete drug development process. Provides accurate and reproducible assessment of drug toxicity across all stages, identifying problems early in the development lifecycle.
Diagnostic Sensitivity
Key Values
Scientific Proof
Key Publications (Biomarkers)
Clinical evidence supporting miR-122 as a superior liver injury biomarker.
Destina Chemistry (DGL-Tech)
Foundational papers on the Destina Chemistry that powers LiverAce™ assays.
Product Characteristics
Kit Specifications
| Parameter | Value |
|---|---|
| Analytes | miRNA-122 |
| Platform | Luminex xMAP® (MAGPIX®, FLEXMAP 3D®, etc.) |
| Detection Method | PCR-Free Destina Chemistry |
| Time to Result | < 5 Hours |
| Sample Volume | 25 µL |
| Sample Type | Serum, Plasma |
| Quantification Range | Absolute (Calibrators included) |
Performance Characteristics
Assay Sensitivity
| Analyte | LOD (pg/mL) | LLOQ (pg/mL) |
|---|---|---|
| miR-122 | 2.4 | 8.23 |
Precision
| Analyte | Intra %CV | Inter %CV |
|---|---|---|
| miR-122 | < 10% | < 20% |
Assay Procedure
Simple, Streamlined, Superior
An immunoassay-like protocol: no RNA extraction and no PCR, so it fits seamlessly into the workflow of any lab already running immunoassays.
1. Add Sample
2. Hybridizing
3. Label
4. Read
Applications & Research Fields
- Pharma R&D & Drug Development
- CROs & Service Labs
- Preclinical Safety Assessment
- Clinical Trials
- Liver Toxicity (DILI) Screening
Documentation
Files are available upon request to ensure you receive the latest version.
Ready to Transform Your Liver Safety Assessment?
Our specialists are ready to discuss your testing needs.
Get in Touch
Place Your Order
LiverAce™ Singleplex Kit
PCR-Free miRNA-122 Detection · For Research Use Only

